Woulfe J, Kertesz A, Munoz DG. Frontotemporal dementia with ubiquitinated cytoplasmic and intranuclear inclusions

Department of Pathology and Molecular Medicine, McMaster University and The Hamilton Regional Laboratory Medicine Program, Hamilton Health Sciences Corporation, Hamilton, Ontario, Canada
Acta Neuropathologica (Impact Factor: 10.76). 01/2001; 102(1):94-102. DOI: 10.1007/s004010000346


Dementia of motor neuron disease type (DMND) is a variety of frontotemporal dementia (FTD) which is pathologically defined by characteristic neuronal ubiquitinated, tau- and synuclein-negative intracytoplasmic inclusions. Many cases with this pathology, however, do not have motor neuron disease. In the present study, we document the presence of ubiquitinated neuronal intranuclear inclusions in a sub-population of cases of neuropathologically verified DMND. Immunohistochemical localization of ubiquitin was performed on sections of post-mortem brain from 12 patients with DMND as well as from cases with other neurodegenerative diseases including amyotrophic lateral sclerosis, Parkinson's disease, dementia with Lewy bodies, corticobasal degeneration, progressive supranuclear palsy, and multiple system atrophy. All of the cases of DMND showed ubiquitinated, tau-negative intracytoplasmic inclusions in dentate granule cells and cortical neurons. Of these 12 cases of DMND, 3 also showed neuronal ubiquitinated intranuclear inclusions. In 1 of these cases, CAG repeat expansions in the genes known to harbor these mutations were excluded. Cases with intranuclear inclusions displayed striatal atrophy and reduced brain weight relative to non-inclusion-bearing cases. In addition, patients with intranuclear inclusions tended to have a younger age of onset, a prolonged duration of disease, absence of motor neuron symptoms, and a family history of dementia. Intranuclear inclusions were not identified in the control cases with other neurodegenerative diseases. Ubiquitinated neuronal intranuclear inclusions have not been reported previously in DMND. The presence of ubiquitinated intranuclear inclusions along with striatal atrophy in a subset of cases of DMND may signify the existence of a neuropathologically distinct subset of this unique form of FTD.

4 Reads
  • Source
    • "Ubiquitin ELISA, cerebrospinal fluid, serum [42 – 45] Parkinson's disease Ubiquitin (+) Immunocytochemistry, brain specimen [57 – 59,62] Parkin (+) Immunocytochemistry, brain specimen [57] Parkin (+) PCR, peripheral blood leukocytes [54] [55] [60] Dementia with Lewy bodies Ubiquitin (+) Immunocytochemistry, brain specimen [38] [58] [59] [64] Pick's disease Ubiquitin (+) Immunocytochemistry, brain specimen [22] [23] [62] [64] Amyotrophic lateral sclerosis Ubiquitin (+) Immunocytochemistry, brain specimen [21] [23] Huntington's disease Ubiquitin (+) Immunocytochemistry, brain specimen [18] [61] Creutzfeld – Jakob disease Ubiquitin (z) RIA, cerebrospinal fluid [65] Cancer Renal cancer Proteasome subunits C2 and C9 (z) PCR, immunocytochemistry, tumor biopsy [107] [108] 20S Proteasome (z) ELISA, serum [105] [106] [109] Gastric cancer 20S Proteasome (z) ELISA, serum [105] [106] [109] Myeloid leukemia 20S Proteasome (z) ELISA, serum [105] [106] [109] Lymphoma 20S Proteasome (z) ELISA, serum [105] [106] Thyroid carcinoma PA28-g (z) Western blot, immunocytochemistry, tumor biopsy [110] Breast, gastric, lung, brain, ovary, prostate, bladder, esophageal cancer p27 (#) Western blot, immunocytochemistry, tumor biopsy [86 – 91] Autoimmune diseases "
    Dataset: cca-golab

  • Source
    • "In the hippocampus, the NCI and NII were counted from sector CA1 to CA2, the short dimension of the contiguous sample field being aligned with the alveus. NCI also occur in the dentate gyrus fascia in FTLD-TDP (Woulfe et el., 2001; Kovari et al., 2004; Mackenzie et al., 2006) and were counted with the sample field aligned with the upper edge of the granule cell layer. The number of NCI and NII were counted in each sample field. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Mutations of the progranulin (GRN) gene are a major cause of familial frontotemporal lobar degeneration with transactive response (TAR) DNA-binding protein of 43 kDa (TDP-43) proteinopathy (FTLD-TDP). We studied the spatial patterns of TDP-43 immunoreactive neuronal cytoplasmic inclusions (NCI) and neuronal intranuclear inclusions (NII) in histological sections of the frontal and temporal lobe in eight cases of FTLD-TDP with GRN mutation using morphometric methods and spatial pattern analysis. In neocortical regions, the NCI were clustered and the clusters were regularly distributed parallel to the pia mater; 58% of regions analysed exhibiting this pattern. The NII were present in regularly distributed clusters in 35% of regions but also randomly distributed in many areas. In neocortical regions, the sizes of the regular clusters of NCI and NII were 400-800 μm, approximating to the size of the modular columns of the cortico-cortical projections, in 31% and 36% of regions respectively. The NCI and NII also exhibited regularly spaced clustering in sectors CA1/2 of the hippocampus and in the dentate gyrus. The clusters of NCI and NII were not spatially correlated. The data suggest degeneration of the cortico-cortical and cortico-hippocampal pathways in FTLD-TDP with GRN mutation, the NCI and NII affecting different clusters of neurons.
    Histology and histopathology 02/2011; 26(2):185-90. · 2.10 Impact Factor
    • "The neuronal inclusions in FTD-U families with PGRN mutations are characterized by the presence of ubiquitin immunoreactive neuronal cytoplasmic inclusions (NCIs), neuronal intranuclear inclusions (NIIs), and dystrophic neurites (DNs).[32] Among these, some NIIs show a characteristic, lentiform morphology.[34] Now, the biochemical composition of the ubiquitinated NCIs, NIIs, and DNs in familial FTD-U was demonstrated as TDP-43 (trans-active response element DNA-binding protein).[3536] "
    [Show abstract] [Hide abstract]
    ABSTRACT: Frontotemporal lobar degeneration (FTLD) is a highly heterogenous group of progressive neurodegenerative disorders characterized by atrophy of prefrontal and anterior temporal cortices. Recently, the research in the field of FTLD has gained increased attention due to the clinical, neuropathological, and genetic heterogeneity and has increased our understanding of the disease pathogenesis. FTLD is a genetically complex disorder. It has a strong genetic basis and 50% of patients show a positive family history for FTLD. Linkage studies have revealed seven chromosomal loci and a number of genes including MAPT, PGRN, VCP, and CHMB-2B are associated with the disease. Neuropathologically, FTLD is classified into tauopathies and ubiquitinopathies. The vast majority of FTLD cases are characterized by pathological accumulation of tau or TDP-43 positive inclusions, each as an outcome of mutations in MAPT or PGRN, respectively. Identification of novel proteins involved in the pathophysiology of the disease, such as progranulin and TDP-43, may prove to be excellent biomarkers of disease progression and thereby lead to the development of better therapeutic options through pharmacogenomics. However, much more dissections into the causative pathways are needed to get a full picture of the etiology. Over the past decade, advances in research on the genetics of FTLD have revealed many pathogenic mutations leading to different clinical manifestations of the disease. This review discusses the current concepts and recent advances in our understanding of the genetics of FTLD.
    Annals of Indian Academy of Neurology 12/2010; 13(Suppl 2):S55-62. DOI:10.4103/0972-2327.74246 · 0.60 Impact Factor
Show more

Similar Publications